Libivirumab
Product Specifications
UNSPSC Description
Libivirumab (17.1.41) is a human anti-HBV monoclonal antibody. Libivirumab shows neutralization activity with IC50s of 35, 130 ng/mL for HBsAg, HBeAg, respectively[1].
Target Antigen
HBV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/libivirumab.html
Purity
98.27
Solubility
10 mM in DMSO
Smiles
[Libivirumab]
References & Citations
[1]Wang Q, et al. A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations. Cell Host Microbe. 2020 Aug 12;28(2):335-349.e6.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99703/Libivirumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99703/Libivirumab-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
569658-79-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6124503-01 0.1 mL
Retinol Binding Protein (Cellular Retinol-binding Protein I, CRBP1, CRBP2, RBP1, RBP2, RBP4, RBPC, Retinol binding Protein 1, Retinol binding Protein 1 Cellular, Retinol binding Protein 2 Cellular, Retinol binding Protein 4 plasma, RBP) (PE)
Ask
View Details MBS6124503-02 5x 0.1 mL
Retinol Binding Protein (Cellular Retinol-binding Protein I, CRBP1, CRBP2, RBP1, RBP2, RBP4, RBPC, Retinol binding Protein 1, Retinol binding Protein 1 Cellular, Retinol binding Protein 2 Cellular, Retinol binding Protein 4 plasma, RBP) (PE)
Ask
View Details